GB2490854B - Method of treatment or prevention of hair loss or for the enhancement of hair growth - Google Patents

Method of treatment or prevention of hair loss or for the enhancement of hair growth

Info

Publication number
GB2490854B
GB2490854B GB1216817.5A GB201216817A GB2490854B GB 2490854 B GB2490854 B GB 2490854B GB 201216817 A GB201216817 A GB 201216817A GB 2490854 B GB2490854 B GB 2490854B
Authority
GB
United Kingdom
Prior art keywords
hair
enhancement
prevention
treatment
hair growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB1216817.5A
Other languages
English (en)
Other versions
GB201216817D0 (en
GB2490854A (en
Inventor
Sadatoshi Sakuma
Maria Halasz
Darren Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advangen International Pty Ltd
Original Assignee
Advangen International Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2010900771A external-priority patent/AU2010900771A0/en
Application filed by Advangen International Pty Ltd filed Critical Advangen International Pty Ltd
Publication of GB201216817D0 publication Critical patent/GB201216817D0/en
Publication of GB2490854A publication Critical patent/GB2490854A/en
Application granted granted Critical
Publication of GB2490854B publication Critical patent/GB2490854B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
GB1216817.5A 2010-02-24 2011-02-23 Method of treatment or prevention of hair loss or for the enhancement of hair growth Expired - Fee Related GB2490854B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2010900771A AU2010900771A0 (en) 2010-02-24 Method of treatment or prevention of hair loss or for the enhancement of hair growth
PCT/AU2011/000194 WO2011103624A1 (en) 2010-02-24 2011-02-23 Method of treatment or prevention of hair loss or for the enhancement of hair growth

Publications (3)

Publication Number Publication Date
GB201216817D0 GB201216817D0 (en) 2012-11-07
GB2490854A GB2490854A (en) 2012-11-14
GB2490854B true GB2490854B (en) 2014-07-16

Family

ID=44506072

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1216817.5A Expired - Fee Related GB2490854B (en) 2010-02-24 2011-02-23 Method of treatment or prevention of hair loss or for the enhancement of hair growth

Country Status (8)

Country Link
US (2) US20130067604A1 (OSRAM)
EP (1) EP2538963B8 (OSRAM)
JP (1) JP5850862B2 (OSRAM)
KR (2) KR20140017416A (OSRAM)
CN (2) CN106075398A (OSRAM)
AU (1) AU2011220326B2 (OSRAM)
GB (1) GB2490854B (OSRAM)
WO (1) WO2011103624A1 (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6193968B2 (ja) * 2012-03-21 2017-09-06 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア 発毛を調節するための組成物および方法
KR101921246B1 (ko) * 2017-01-04 2018-11-22 주식회사 베스트앤퍼스트바이오텍 탈모 방지 및 양모를 위한 헤어 필러 조성물 및 그 제조 방법
FR3061656B1 (fr) * 2017-01-09 2019-05-24 Societe Industrielle Limousine D'application Biologique Hydrolysat de pichia minuta et utilisation cosmetique pour lutter contre la chute des cheveux et favoriser leur repousse
CN108014328A (zh) * 2017-12-19 2018-05-11 吴广印 一种预防脱发、促进生发物质的配方及其制备方法
CN111991413B (zh) * 2020-09-18 2021-10-08 中国人民解放军陆军特色医学中心 一种预防脱发或促进毛发生长的多糖组合物及其制剂和应用
US20240269240A1 (en) * 2023-02-15 2024-08-15 Blue Blood Biotech Corporation Compositions and methods for treating hair loss or facilitating hair growth

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030202960A1 (en) * 1998-04-17 2003-10-30 Colley Kenneth J. Therapeutic angiogenic factors and methods for their use

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4139619A (en) 1976-05-24 1979-02-13 The Upjohn Company 6-Amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidine, topical compositions and process for hair growth
JPH04224522A (ja) * 1990-04-27 1992-08-13 Merck & Co Inc 繊維芽細胞増殖因子含有組成物による禿頭症の治療又は予防方法
US5486509A (en) * 1991-06-28 1996-01-23 University Of Miami Method of preventing and treating chemotherapy-induced alopecia
JPH05124935A (ja) * 1991-10-31 1993-05-21 Kao Corp 毛成長促進剤
US5767152A (en) * 1995-05-04 1998-06-16 Nielsen; Thor Bagger Composition and methods for stimulating hair growth
JPH09157183A (ja) * 1995-12-07 1997-06-17 Meiji Milk Prod Co Ltd 皮膚外用剤
JP3667027B2 (ja) * 1997-03-06 2005-07-06 株式会社ノエビア 皮膚外用剤
JPH10251158A (ja) * 1997-03-06 1998-09-22 Noevir Co Ltd 皮膚外用剤
CN1331155A (zh) * 2000-06-28 2002-01-16 上海博德基因开发有限公司 一种新的多肽——人肝素结合生长因子受体K－ram9.13和编码这种多肽的多核苷酸
US20030215412A1 (en) * 2000-07-21 2003-11-20 Essentia Biosystems, Inc. Induction of hair growth with vascular endothelial growth factor
AU2003216389A1 (en) * 2002-02-21 2003-09-09 Essentia Biosystems, Inc. Induction of hair growth with vascular endothelial growth factor
WO2005001044A2 (en) * 2003-05-29 2005-01-06 Angiogenix, Inc. Compositions related to pleiotrophin methods and uses thereof
TWI348386B (en) * 2003-08-12 2011-09-11 R Tech Ueno Ltd Composition and method for promoting hair growth
BRPI0507669A (pt) * 2004-02-12 2007-07-17 Warner Lambert Co método para estimular crescimento de cabelo

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030202960A1 (en) * 1998-04-17 2003-10-30 Colley Kenneth J. Therapeutic angiogenic factors and methods for their use

Also Published As

Publication number Publication date
KR101953742B1 (ko) 2019-03-04
US20130067604A1 (en) 2013-03-14
GB201216817D0 (en) 2012-11-07
US9622955B2 (en) 2017-04-18
CN106075398A (zh) 2016-11-09
EP2538963A1 (en) 2013-01-02
KR20140017416A (ko) 2014-02-11
CN102791284A (zh) 2012-11-21
AU2011220326B2 (en) 2014-11-20
WO2011103624A1 (en) 2011-09-01
EP2538963B8 (en) 2017-08-02
JP2013520447A (ja) 2013-06-06
US20150044139A1 (en) 2015-02-12
EP2538963A4 (en) 2013-09-11
EP2538963B1 (en) 2017-05-17
AU2011220326A1 (en) 2012-08-23
KR20180056814A (ko) 2018-05-29
GB2490854A (en) 2012-11-14
JP5850862B2 (ja) 2016-02-03

Similar Documents

Publication Publication Date Title
IL261768B (en) Devices and methods for tissue treatment
GB2511995B (en) Apparatus for stimulating hair growth and/or preventing hair loss
ZA201303605B (en) Compounds and methods for treating pain
EP2621420A4 (en) CORNEAL TREATMENT SYSTEM AND METHOD
IL214664A0 (en) Methods of treating hair related conditions
SG2014014724A (en) METHODS FOR THE TREATMENT OF IL-1ß RELATED CONDITIONS
GB201018147D0 (en) Method of treatment
ZA201402450B (en) Method for the fungicidal and /or bactericidal treatment of resistant strains using one or more essential oils
ZA201306388B (en) Methods and compositions for treating,reducing,or preventing deterioration of the visual system of animals
PT3581199T (pt) Métodos de tratamento ou redução de paniculopatia edematosa fibroesclerótica
ZA201303222B (en) Composition and method for treating skin conditions
EP2538791A4 (en) Growth Factor Compositions From Thrombocytes And Methods Of Treating Tendinopathia
IL225793A0 (en) Methods and preparations for curing insulin-related medical conditions
ZA201209323B (en) Methods of treating or preventing estrogen-related diseases
IL220594A0 (en) Treatment method
IL256026B (en) Treatment methods
GB201003920D0 (en) Method of treatment
GB201001412D0 (en) Propolis and process for the treatment thereof
GB2490854B (en) Method of treatment or prevention of hair loss or for the enhancement of hair growth
SI2731616T1 (sl) Postopek preventive in zdravljenja sepse
IL225755B (en) amido derivatives - 6 of epoxymorphinans - a5, 4 for the treatment of pain
ZA201108493B (en) Method of treating hair
PL2744601T3 (pl) Sposób i instalacja do obróbki przedmiotów
GB201018149D0 (en) Method of treatment
GB201020045D0 (en) Method for the treatment of biogas

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20250223